Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
Gabriel C Léger , Fadi Massoud
Expert Review of Clinical Pharmacology 6 ( 4) 423 -442
6
2013
Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes
Justin B Miller , Sarah J Banks , Gabriel C Léger , Jeffrey L Cummings
Translational neurodegeneration 3 ( 1) 12 -12
15
2014
Pharmacological Treatment of Alzheimer Disease
Fadi Massoud , Gabriel C Léger
The Canadian Journal of Psychiatry 56 ( 10) 579 -588
131
2011
Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer’s Disease
Neal R Swerdlow , Yash B Joshi , Joyce Sprock , Jo Talledo
Journal of Alzheimer's Disease 91 ( 1) 355 -362
1
2023
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam)
Howard H Feldman , José A Luchsinger , Gabriel C Léger , Curtis Taylor
Plos one 19 ( 5) e0302998 -e0302998
2024
Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration
Marijne Vandebergh , Eliana Marisa Ramos , Nick Corriveau-Lecavalier , Vijay K Ramanan
medRxiv
2024
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
Adam M Staffaroni , Annie L Clark , Jack C Taylor , Hilary W Heuer
JAMA Network Open 7 ( 4) e244266 -e244266
2024
Association of Neurofibrillary Tangle Distribution With Age at Onset–Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study
Denis S Smirnov , David P Salmon , Douglas Galasko , Vanessa S Goodwill
Neurology 98 ( 5) e506 -e517
15
2022
Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease
Sheridan D Chappelle , Christina Gigliotti , Gabriel C Léger , Guerry M Peavy
Alzheimer's & Dementia 19 ( 10) 4599 -4608
2
2023
Frontotemporal Dementia
Gabriel C Léger ,
Neuro-Geriatrics: A Clinical Manual 103 -124
2017
The Canadian Review of
Marie-Pierre Thibodeau , Howard Chertkow , Gabriel C Léger , Ryan D Rajaram
The Canadian Review of 12 ( 2)
2009
La Revue canadienne
Marie-Pierre Thibodeau , Howard Chertkow , Gabriel C Léger , Ryan D Rajaram
2009
Alzheimer's Disease
Jose A Soria Lopez , Hector M González , Gabriel C Léger
Smpte Journal
341
1998
A review on primary progressive aphasia
Gabriel C Léger , Nancy Johnson
Neuropsychiatric disease and treatment 3 ( 6) 745 -752
18
2007
Anticholinergic drug burden and neurocognitive performance in the study of latinos-investigation of neurocognitive aging
Alexander Ivan B Posis , Wassim Tarraf , Kevin A Gonzalez , Jose A Soria-Lopez
Journal of Alzheimer's Disease 86 ( 1) 53 -65
2
2022
Case report: Neuronal intranuclear inclusion disease presenting with acute encephalopathy
Julia Ting Bu , Dolores Torres , Adam Robinson , Corey Malone
Frontiers in Neurology 14 1184612 -1184612
2023
Troubles cognitifs et psychiatriques
Isabelle Michaud , Nathalie Shamlian , Gabriel C Léger
Advanced Search Search
Christina A Alexandres , Stuart J McCarter , Grace M Tabatabai , Laurene LeClair-Visonneau
Gene
2024
Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.
Gabriel L�ger , Albert Gjedde , Hiroto Kuwabara , Mark Guttman
Synapse 30 ( 4) 351 -361
16
1998
Prognostic value of plasma biomarkers in a clinical trial of mild‐to‐moderate Alzheimer’s Disease
Yuqi Qiu , Karen Messer , Diane M Jacobs , David P Salmon
Alzheimer's & Dementia 19 e076047 -e076047
2023